Skip to main content

Blaug Suzanne's Form 4 filing

Kyntra Bio, Inc. (KYNB) · filed Jun 9, 2023

Accession no.
0001209191-23-036079
Filed
Jun 9, 2023
Trade date
Jun 7-9, 2023
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $146.6K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Blaug SuzanneCIK 0001778430Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 7, 2023Common StockAGrant or awardAcquired+8,289$0.00$038,114Direct
Jun 9, 2023Common StockSSaleDisposed−3,351$16.73−$56,062.2334,763Direct
Jun 9, 2023Common StockSSaleDisposed−5,169$17.51−$90,509.1929,594Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 7, 2023Common StockAGrant or awardAcquired+12,666$0.00$012,666Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)